Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 68.24 ACUITE BB+ | Reaffirmed & Withdrawn -
Bank Loan Ratings 13.26 Not Applicable | Withdrawn -
Total Outstanding 0.00 - -
Total Withdrawn 81.50 - -
 
Rating Rationale

Acuite has reaffirmed and withdrawn the long-term rating of ‘ACUITE BB+' (read as ACUITE double B plus) on the Rs. 68.24 Cr. bank facilities of Nubeno Healthcare Private Limited (NHPL). The rating has been withdrawn on account of the request received from the company and the NOC (No Objection Certificate) received from the bankers.
Acuite has withdrawn the long-term rating on Rs. 13.26 Cr. facility without assigning any rating as it is a proposed facility of Nubeno Healthcare Private Limited (NHPL). The rating has been withdrawn on account of the request received from the company.
The rating has been withdrawn on Acuité's policy of withdrawal of ratings as applicable to the respective instrument/facility.

Rationale for Rating
The rating factors NHPL’s improved scale of operations to Rs. 96.21 Cr. in FY25(Provisional) against Rs. 64.24 Cr. in FY24 albeit moderation in net profitability of 4.02% in FY25(Provisional) against 4.71% in FY24 because of the increased interest expenses. The company has also completed the capital expenditure in December 2023 for which it has started to reap benefits in terms of increased supply of syringes, IV Cannulas and 3 stop cocks. The rating further draws comfort from the experienced management and diversified geographical presence. While the financial risk profile is moderate, with increased debt from capex, liquidity remains adequate. The rating is constrained by substantial working capital requirements.


About the Company

­Incorporated in 2018, Maharashtra based Nubeno Healthcare Private Limited (NHPL) is engaged in manufacturing of medical equipment and surgical items such as intravenous (IV) cannula, syringes etc. Promoted by Nagpur based ‘Navbharat’ Group, the Company is owned and operated by Mr. Vaibhav Nimish Maheshwari and Mr. Raghav Nimish Maheshwari along with other family members.

 
Unsupported Rating

Not Applicable

 
Analytical Approach

­Acuité has considered the standalone financial and business risk profiles of NHPL to arrive at the rating

 
Key Rating Drivers

Strengths

Resourceful promoters, experienced management and diversified geographical presence, albeit limited track record of operations
NHPL is promoted by Nagpur based ‘Navbharat’ Group. The group is an established name in the newsprint business. Promoted by the Maheshwari family, the Group is headed by Mr. Nimish Maheshwari who has an overall experience of over 30 years of leading the Group in publishing, paper manufacturing & real estate development. NHPL is a first venture of the Group in the medical devices industry. NHPL is owned and operated by his two sons Mr. Vaibhav Maheshwari and Mr. Raghav Maheshwari along with other family members. The promoters are ably supported by an experienced management team with an average industry experience of more than two decades. The company has diversified geographical presence. It sells across various states of Kolkata, Orissa, Assam, Bihar, MP and others in the domestic market and exports to Bhutan, Ghana, UAE, UK and others. Acuité believes that the NHPL will continue to benefit from the experience of its promoters and management team and diversified geographical presence over the medium term.
Improved scale of operations and moderation in profitability margins
The company have achieved a revenue of Rs. 96.21 Cr. in FY25(Provisional) against Rs. 64.24 Cr. in FY24. The increase of 49.78% is attributed to the increase the manufacturing capacity leading to increased sales. The EBITDA margins of the company stood at 14.24% in FY25(Provisional) against 12.80% in FY24. The increase in the operating margins was observed because of the slight decrease in the raw material. The raw material used by the company is medical grade plastics which is a crude oil derivative. The prices of crude oil were observed to remain above the mean levels during FY24; however correction was noticed during FY25. The PAT margins of the company stood at 4.02% in FY25(Provisional) against 4.71% in FY24. Going forward, the company is likely to improve the topline by sustaining profitability over the medium term on account of corrections noticed in raw material prices and increased production capacity. NHPL does not have any forex hedging policies for its export operations.
Moderate Financial Risk Profile
The financial risk profile of the company is moderate marked by tangible net-worth of Rs. 40.05 Cr. as on 31st March 2025(Provisional) against Rs. 36.18 Cr. as on 31st March 2024. The net worth also consists of unsecured loans treated as quasi equity worth Rs. 9.58 Cr. in FY25. The unsecured loans have been treated as quasi equity due to subordination clause of the banker’s stipulation. The total debt of the company is Rs. 67.66 Cr. as on 31st March 2025(Provisional) against Rs. 65.23 Cr. as on 31st March 2024. The gearing stands average at 1.69 times in FY25(Provisional) as against 1.80 times in FY24. Further, the interest coverage ratio of the company stood at 2.75 times in FY25(Provisional) as against 4.26 times in FY24. The debt service coverage ratio stood at 1.07 times in FY25(Provisional) as against 1.62 times in FY24. The DSCR has observed a decline because of the increased debt repayment obligations and the rising interest costs on the same with additional working capital requirement being fulfilled with the help of the increased cash credit limits by PNB from Rs. 4 Cr. to Rs. 9.5 Cr. The TOL/TNW stood at 2.21 times in FY25(Provisional) and the NCA/TD stood at 0.13 times in FY25(Provisional) as against 0.08 times in FY24. Acuité believes that the financial risk profile of NHPL is likely to remain moderate over the medium term.


Weaknesses

Intensive Working Capital Operations
The working capital operations of the company remained intensive marked by GCA days which stood at 143 days in FY25(Provisional) as against 182 days as on as on 31st March 2024. The increase in the GCA days was observed because of slight increase in the debtor collection period. The inventory and debtor days of the company stood at 51 days and 66 days respectively as on 31st March 2025(Provisional) against 74 days and 62 days respectively as on 31st March 2024. The inventory days noticed a decline on account of better inventory management and increased export orders. On the other hand, the creditor days of the company stood at 69 days as on 31st March 2025(Provisional). The company has been trying to manage the working capital by maintaining better relations with the suppliers and getting better credit periods. Acuité believes that NHPL is likely to improve on account of better inventory management and better relations with the suppliers and customers.

Susceptibility of profitability margins to volatility in raw material prices
The company is primarily engaged into manufacturing of IV cannula and syringes. The key input material for the products is medical grade polymer resins, which is crude oil derivative. The price of this commodity is subject to volatility in line with those of global crude oil prices. This exposes the profitability margins of NHPL to fluctuations in raw material prices.

Rating Sensitivities

Not Applicable

 
Liquidity Position
Adequate

The liquidity profile of the company is adequate. The company generated a net cash accrual of Rs. 8.71 Cr. as on as on 31st March 2025(Provisional) against the debt repayment obligations of Rs. 7.83 Cr. in the same period. The current ratio of the company declined to 1.31 times as on 31st March 2025(Provisional) against 1.23 times as on 31st March 2024. The company also aims to generate sufficient net cash accruals which will help them to fulfil the debt repayment obligations in the future. Further, the average bank limit utilization at the month end balance stood low at 24% for 6 months ending February 2025.  However, the average maximum limit utilized during the month stood at 76% for 6 month ended February 2025. Acuité believes that the liquidity of NHPL is likely to remain adequate over the medium term on account of steady cash accruals and no debt funded CAPEX plans in near future.

 
Outlook: Not Applicable
­
 
Other Factors affecting Rating

­None

 

Particulars Unit FY 25 (Provisional) FY 24 (Actual)
Operating Income Rs. Cr. 96.21 64.24
PAT Rs. Cr. 3.87 3.02
PAT Margin (%) 4.02 4.71
Total Debt/Tangible Net Worth Times 1.69 1.80
PBDIT/Interest Times 2.75 4.26
Status of non-cooperation with previous CRA (if applicable)

­Not Applicable

 
Interaction with Audit Committee anytime in the last 12 months (applicable for rated-listed / proposed to be listed debt securities being reviewed by Acuite)
Not applicable
Any other information

None

 
Applicable Criteria
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
02 Apr 2025 Term Loan Long Term 2.27 ACUITE BB+ | Stable (Reaffirmed)
Cash Credit Long Term 9.50 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 10.85 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 4.49 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 1.76 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 3.95 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 35.42 ACUITE BB+ | Stable (Reaffirmed)
Proposed Long Term Bank Facility Long Term 13.26 ACUITE BB+ | Stable (Reaffirmed)
16 Jan 2024 Cash Credit Long Term 4.00 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 13.47 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 4.90 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 2.49 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 7.25 ACUITE BB+ | Stable (Reaffirmed)
Term Loan Long Term 37.50 ACUITE BB+ | Stable (Assigned)
Proposed Long Term Bank Facility Long Term 5.24 ACUITE BB+ | Stable (Reaffirmed)
Proposed Long Term Bank Facility Long Term 6.65 ACUITE BB+ | Stable (Assigned)
31 Oct 2022 Cash Credit Long Term 4.00 ACUITE BB+ | Stable (Assigned)
Term Loan Long Term 16.50 ACUITE BB+ | Stable (Assigned)
Term Loan Long Term 6.00 ACUITE BB+ | Stable (Assigned)
Term Loan Long Term 3.50 ACUITE BB+ | Stable (Assigned)
Term Loan Long Term 7.35 ACUITE BB+ | Stable (Assigned)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Punjab National Bank Not avl. / Not appl. Cash Credit 26 Feb 2021 Not avl. / Not appl. Not avl. / Not appl. 9.50 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Not Applicable Not avl. / Not appl. Proposed Long Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 13.26 Simple Not Applicable|Withdrawn
Small Industries Development Bank of India Not avl. / Not appl. Term Loan 29 Nov 2024 Not avl. / Not appl. 10 Apr 2029 2.27 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Punjab National Bank Not avl. / Not appl. Term Loan 22 May 2020 Not avl. / Not appl. 30 Sep 2028 10.85 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Punjab National Bank Not avl. / Not appl. Term Loan 31 Dec 2021 Not avl. / Not appl. 31 Dec 2026 4.49 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Punjab National Bank Not avl. / Not appl. Term Loan 31 Aug 2021 Not avl. / Not appl. 30 Jun 2028 1.76 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Punjab National Bank Not avl. / Not appl. Term Loan 31 May 2020 Not avl. / Not appl. 30 Sep 2028 3.95 Simple ACUITE BB+ | Reaffirmed & Withdrawn
Punjab National Bank Not avl. / Not appl. Term Loan 09 Feb 2022 Not avl. / Not appl. 27 Mar 2031 35.42 Simple ACUITE BB+ | Reaffirmed & Withdrawn

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in